Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04693468
Title Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center

Advanced Solid Tumor


Axitinib + Talazoparib

Crizotinib + Talazoparib

Palbociclib + Talazoparib

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST